2022

Looking back: Identifying supportive care and unmet needs of parents of children receiving specialist paediatric palliative care from the bereavement perspective
Bronsema A, Theißen T, Oechsle K, Wikert J, Escherich G, Rutkowski S, Bokemeyer C, Ullrich A
BMC PALLIAT CARE. 2022;21(1):.

Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
Das A, Sudhaman S, Morgenstern D, Coblentz A, Chung J, Stone S, Alsafwani N, Liu Z, Karsaneh O, Soleimani S, Ladany H, Chen D, Zatzman M, Cabric V, Nobre L, Bianchi V, Edwards M, Sambira Nahum L, Ercan A, Nabbi A, Constantini S, Dvir R, Yalon-Oren M, Campino G, Caspi S, Larouche V, Reddy A, Osborn M, Mason G, Lindhorst S, Bronsema A, Magimairajan V, Opocher E, De Mola R, Sabel M, Frojd C, Sumerauer D, Samuel D, Cole K, Chiaravalli S, Massimino M, Tomboc P, Ziegler D, George B, Van Damme A, Hijiya N, Gass D, McGee R, Mordechai O, Bowers D, Laetsch T, Lossos A, Blumenthal D, Sarosiek T, Yen L, Knipstein J, Bendel A, Hoffman L, Luna-Fineman S, Zimmermann S, Scheers I, Nichols K, Zapotocky M, Hansford J, Maris J, Dirks P, Taylor M, Kulkarni A, Shroff M, Tsang D, Villani A, Xu W, Aronson M, Durno C, Shlien A, Malkin D, Getz G, Maruvka Y, Ohashi P, Hawkins C, Pugh T, Bouffet E, Tabori U
NAT MED. 2022;28(1):125-135.

ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant
Holsten T, Bronsema A, Sturm D, Sahm F, Rutkowski S, Ulrich S, Wößmann W, Kordes U
PEDIATR BLOOD CANCER. 2022;69(8):.

Long-term survival of an adolescent glioblastoma patient under treatment with vinblastine and valproic acid illustrates importance of methylation profiling
Kresbach C, Bronsema A, Guerreiro H, Rutkowski S, Schüller U, Winkler B
CHILD NERV SYST. 2022;38(2):479-483.

2021

DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells
Chung J, Maruvka Y, Sudhaman S, Kelly J, Haradhvala N, Bianchi V, Edwards M, Forster V, Nunes N, Galati M, Komosa M, Deshmukh S, Cabric V, Davidson S, Zatzman M, Light N, Hayes R, Brunga L, Anderson N, Ho B, Hodel K, Siddaway R, Morrissy A, Bowers D, Larouche V, Bronsema A, Osborn M, Cole K, Opocher E, Mason G, Thomas G, George B, Ziegler D, Lindhorst S, Vanan M, Yalon-Oren M, Reddy A, Massimino M, Tomboc P, Van Damme A, Lossos A, Durno C, Aronson M, Morgenstern D, Bouffet E, Huang A, Taylor M, Villani A, Malkin D, Hawkins C, Pursell Z, Shlien A, Kunkel T, Getz G, Tabori U
CANCER DISCOV. 2021;11(5):1176-1191.

Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance
Durno C, Ercan A, Bianchi V, Edwards M, Aronson M, Galati M, Atenafu E, Abebe-Campino G, Al-Battashi A, Alharbi M, Azad V, Baris H, Basel D, Bedgood R, Bendel A, Ben-Shachar S, Blumenthal D, Blundell M, Bornhorst M, Bronsema A, Cairney E, Rhode S, Caspi S, Chamdin A, Chiaravalli S, Constantini S, Crooks B, Das A, Dvir R, Farah R, Foulkes W, Frenkel Z, Gallinger B, Gardner S, Gass D, Ghalibafian M, Gilpin C, Goldberg Y, Goudie C, Hamid S, Hampel H, Hansford J, Harlos C, Hijiya N, Hsu S, Kamihara J, Kebudi R, Knipstein J, Koschmann C, Kratz C, Larouche V, Lassaletta A, Lindhorst S, Ling S, Link M, Loret De Mola R, Luiten R, Lurye M, Maciaszek J, MagimairajanIssai V, Maher O, Massimino M, McGee R, Mushtaq N, Mason G, Newmark M, Nicholas G, Nichols K, Nicolaides T, Opocher E, Osborn M, Oshrine B, Pearlman R, Pettee D, Rapp J, Rashid M, Reddy A, Reichman L, Remke M, Robbins G, Roy S, Sabel M, Samuel D, Scheers I, Schneider K, Sen S, Stearns D, Sumerauer D, Swallow C, Taylor L, Thomas G, Toledano H, Tomboc P, Van Damme A, Winer I, Yalon M, Yen L, Zapotocky M, Zelcer S, Ziegler D, Zimmermann S, Hawkins C, Malkin D, Bouffet E, Villani A, Tabori U
J CLIN ONCOL. 2021;39(25):2779-2790.

2019

Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy
Krull K, Kunstreich M, Bronsema A, Bleckmann K, Classen C, Erdlenbruch B, Jorch N, Kolb R, Leipold A, Moser O, Prokop A, Scheurlen W, Steinbach D, Klasen-Sansone J, Klee D, Escherich G, Moericke A, Schrappe M, Borkhardt A, Kuhlen M
LEUKEMIA LYMPHOMA. 2019;60(1):78-84.

2017

Comprehensive Analysis of Hypermutation in Human Cancer
Campbell B, Light N, Fabrizio D, Zatzman M, Fuligni F, de Borja R, Davidson S, Edwards M, Elvin J, Hodel K, Zahurancik W, Suo Z, Lipman T, Wimmer K, Kratz C, Bowers D, Laetsch T, Dunn G, Johanns T, Grimmer M, Smirnov I, Larouche V, Samuel D, Bronsema A, Osborn M, Stearns D, Raman P, Cole K, Storm P, Yalon M, Opocher E, Mason G, Thomas G, Sabel M, George B, Ziegler D, Lindhorst S, Issai V, Constantini S, Toledano H, Elhasid R, Farah R, Dvir R, Dirks P, Huang A, Galati M, Chung J, Ramaswamy V, Irwin M, Aronson M, Durno C, Taylor M, Rechavi G, Maris J, Bouffet E, Hawkins C, Costello J, Meyn M, Pursell Z, Malkin D, Tabori U, Shlien A
CELL. 2017;171(5):1042-1056.e10.

Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapy
Kuhlen M, Bleckmann K, Möricke A, Schrappe M, Vieth S, Escherich G, Bronsema A, Vonalt A, Queudeville M, Zwaan C, Ebinger M, Debatin K, Klingebiel T, Koscielniak E, Rossig C, Burkhardt B, Kolb R, Eckert C, Borkhardt A, von Stackelberg A, Chen-Santel C
BRIT J HAEMATOL. 2017;179(2):272-283.

2014

The PML domain of PML-RARα blocks senescence to promote leukemia
Korf K, Wodrich H, Haschke A, Ocampo C, Harder L, Gieseke F, Pollmann A, Dierck K, Prall S, Staege H, Ma H, Horstmann M, Evans R, Sternsdorf T
P NATL ACAD SCI USA. 2014;111(33):12133-8.

2005

Osteosarcoma cell lines display variable individual reactions on wildtype p53 and Rb tumour-suppressor transgenes.
Hellwinkel O, Müller J, Pollmann A, Kabisch H
J GENE MED. 2005;7(4):407-419.

2004

Limited specificity of promoter constructs for gene therapy in osteosarcoma.
Pollmann A, Kabisch H, Block A, Müller J, Hellwinkel O
INT J MOL MED. 2004;14(4):737-742.

Letzte Aktualisierung aus dem FIS: 18.11.2024 - 02:53 Uhr